UPDATE: Jefferies Raises PT on Humana Ahead of 2Q Earnings Report
In a report published Wednesday, Jefferies analyst David Windley reiterated a Buy rating on Humana (NYSE: HUM), and raised the price target from $95.00 to $98.00.
In the report, Jefferies noted, “We expect MCOs to report 2Q earnings upsides. MCO commentary suggests utilization remains favorable, corroborated by Tenet's weak inpatient volumes and ISRG's weak capital equipment sales. We also highlight hot topics and headlines ahead of a flurry of important events over the next several months. AET remains our top MCO pick. We are modestly raising PTs for Diversifieds (still trading at a discount) on more stable outlooks.”
Humana closed on Tuesday at $85.18.
Latest Ratings for HUM
|Dec 2016||Cantor Fitzgerald||Downgrades||Buy||Hold|
|Nov 2016||Credit Suisse||Upgrades||Neutral||Outperform|
|Nov 2016||JP Morgan||Upgrades||Neutral||Overweight|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.